Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Travel funding 2024 Switzerland, Swiss Nordic Bio, 7 mars

Reference number
Coordinator MyCural Therapeutics AB
Funding from Vinnova SEK 15 000
Project duration March 2024 - March 2024
Status Completed
Venture Global cooperation 2024

Last updated 12 April 2024

Reference number 2024-00330